pharmaphorum

JUNE 13, 2022

Canary Wharf’s bid to become a new hub for the life sciences sector in the UK has been given a boost following the decision by Genomics England to relocate to the development. ” The post Genomics England will move HQ to Canary Wharf’s new biocluster appeared first on. .

Genome 106

Genome Genomics Life Science Genome Project 106

Drug Discovery World

JANUARY 29, 2024

Leading experts in genomics, personalised medicine and drug discovery convened at the Precision Medicine Community Event in London to unveil the latest advancements shaping the future of healthcare. The post What are the key trends in genomics and precision medicine for 2024? appeared first on Drug Discovery World (DDW).

Genome 59

Genome Genomics Medicine Biobanking 59

BioSpace

JUNE 13, 2022

Researchers from the Dana-Farber Cancer Institute looked deeper into a non-coding portion of the human genome, uncovering mechanisms that might drive or suppress cancer development.

Genome 84

Genome Genomics Research Development 84

Drug Discovery World

DECEMBER 29, 2023

Known as ‘CReATiNG’ (Cloning Reprogramming and Assembling Tiled Natural Genomic DNA), the method offers a simpler and more cost-effective approach to constructing synthetic chromosomes. The thing about most synthetic genomics research is that it involves building chromosomes or genomes from scratch using chemically synthesised DNA pieces.

Genome 52

Genome Genomics DNA Scientist 52

Drug Discovery Today

OCTOBER 27, 2022

The country now hosts the EMBL Partnership Institute for Genome Editing Technologies at the Vilnius University Life Sciences Center aiming to advance gene editing technologies. Six international research groups work at the EMBL Partnership Institute in Vilnius, each tackling a different facet of gene editing. One of them is the Jones!Lab,

Genome 85

Genome Genomics Gene Editing Life Science 85

STAT News

AUGUST 17, 2022

When the Smithsonian National Museum of Natural History opened its genomics exhibit in 2013, the field was just celebrating the 10th anniversary of the completed Human Genome Project. Sequencing that first genome cost over $500 million. The genomes since cost $10,000. The development of CRISPR-Cas9 landed a Nobel Prize.

Genome 98

Genome Genomics Genome Project DNA 98

pharmaphorum

OCTOBER 31, 2022

Verge Genomics has joined a select group of biotechs who have taken a drug discovered and developed using artificial intelligence into human testing. The post Verge Genomics takes AI-sourced drug for ALS into clinic appeared first on.

Genome 126

Genome Genomics Drugs RNA 126

BioSpace

AUGUST 30, 2020

When Bionano Genomics acquired Lineagen, Inc. in August, the genomic analysis company gained the final piece it needed to provide comprehensive structural variation detection for researchers and drug developers and a reimbursement pathway for clinicians who want to use its technology to replace c.

Genome 132

Genome Genomics Development Drugs 132

Pharmaceutical Technology

JUNE 16, 2023

The deal is aimed at advancing life sciences across three strategic areas: clinical and translational research, capacity building and technology transfer, and in the area of commercialisation.

Life Science 130

Life Science Genetic Disease Genome Genomics 130

pharmaphorum

MARCH 23, 2022

With initiatives like The 100,000 Genome Project, the UK has led the world on genomic research. Representatives from industry associations and the governments and NHS in all four UK nations will meet to discuss the future of the country’s genomics sector. It also recognises that our ambition needs to be to create scale.”.

Genome 72

Genome Genomics Genome Project Life Science 72

Drug Discovery World

OCTOBER 25, 2022

A new laboratory specialising in genomics is set to open at the North Carolina Research Campus (NCRC) in Kannapolis, North Carolina. The Bill and Shari Graham Genomics Laboratory is a collaborative project from Catawba College and Eremid Genomic Services.

Genome 52

Genome Genomics DNA Research 52

Drug Discovery World

OCTOBER 26, 2022

A study by the Qatar Genome Research Consortium, led by Dr Lotfi Chouchane from Weill Cornell Medicine-Qatar, has reported the first landscape of cancer germline mutations – hereditary mutations – in the Qatari population. . These variants increase the risk of developing breast cancer in women and prostate cancer in men. .

Genome 52

Genome Genomics Biobanking Genetics 52

pharmaphorum

OCTOBER 19, 2022

million ($40 million) first-round financing that will be used to explore so-called ‘dark’ regions of the human genome. M Ventures’ Dr Bauke Anninga said that that the startup has a “differentiated platform technology has the potential to fundamentally shift the way we discover and develop precision medicines.

Genome 59

Genome Genomics Gene Gene Expression 59

Drug Discovery World

AUGUST 16, 2023

Therefore, it is now more critical than ever to advance the science to develop the next generation of RNA therapies, leveraging this molecule as a therapeutic modality with transformational potential. In actuality, the protein-coding portion of our genome is comparable in identity and number with the humble fruit fly or worm.

RNA 52

RNA Genome Genomics DNA 52

Scienmag

AUGUST 7, 2020

Credit: UTHSC Neil Hayes, MD, MS, MPH, division chief of Hematology and Oncology at the University of Tennessee Health Science Center, is among recipients of the 2020 Team Science Awards from the American Association for Cancer Research (AACR) for his contributions to developing The Cancer Genome Atlas (TCGA), a groundbreaking multisite project to (..)

Genome 86

Genome Genomics Research Development 86

Pharmaceutical Technology

SEPTEMBER 1, 2022

Guardant Health has extended a partnership with Merck KGaA, Darmstadt, Germany, to aid in expediting precision oncology therapeutics development. Under the collaboration, the companies will use the GuardantINFORM real-world evidence (RWE) platform to boost works for developing Merck’s precision cancer pipeline.

Development 162

Development Genome Genomics Medicine 162

BioTech 365

DECEMBER 14, 2021

Gretel and Illumina Partner to Develop Synthetic Data for Genomic Research Gretel and Illumina Partner to Develop Synthetic Data for Genomic Research The partnership utilizes the highest-quality synthetic data in the market from Gretel to remove privacy bottlenecks and accelerate … Continue reading →

Genome 52

Genome Genomics Development Research 52

pharmaphorum

AUGUST 4, 2022

Unlocking the secrets of the human genome has long been an ambitious pursuit for researchers around the world. Today, the landscape of genomic testing and research is rapidly progressing, with significant scientific and technological advances driving a paradigm shift in the understanding of oncology at a molecular level.

Genome 52

Genome Genomics Genome Project DNA 52

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 1, 2022

As drug companies have embarked on an initiative to launch affordable medicines for rare diseases in India, experts have called for using pharmacogenetics to develop treatments and whole genome sequencing to identify etiologies. There […].

Development 175

Development Genome Genomics Medicine 175

Scienmag

JULY 8, 2021

Study shows 70% of people who use the workbook discuss their disease risks and health history with family members Credit: Harry Wedel, NHGRI Researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), have developed the Families Sharing Health Assessment and Risk Evaluation (SHARE) workbook, (..)

Genome 70

Genome Genomics Research Development 70

Drug Discovery World

NOVEMBER 7, 2022

A new study led by Medical Research Council-funded researchers from UCL has found that tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases. . Consequently, the UK has established itself at the forefront of diagnostic whole genome sequencing.

Genome 52

Genome Genomics Genetics Genetic Disease 52

Roots Analysis

FEBRUARY 27, 2024

The global genome editing market is anticipated to grow at a CAGR of 12.6% The global genome editing market is anticipated to grow at a CAGR of 12.6% The biopharmaceutical pipeline includes close to 500 gene therapies , several of which are being developed based on CRISPR technology. during the forecast period 2023-2035.

Genome 40

Genome Genomics Gene Gene Editing 40

BioTech 365

DECEMBER 9, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Researchers develop rapid genomics strategy to trace coronavirus.Thanks to cutting-edge ‘Nanopore’ genome sequencing technology, researchers at the Garvan Institute of Medical Research and the Kirby Institute at … (..)

Genome 40

Genome Genomics Development Research 40

BioTech 365

SEPTEMBER 3, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Researchers develop an engineered ‘mini’ CRISPR genome editing system.The common analogy for CRISPR gene editing is that it works like molecular scissors, cutting out select sections of … Continue reading → (..)

Engineer 40

Engineer Genome Genomics Gene Editing 40

Drug Discovery World

APRIL 10, 2023

Although pharmaceutical companies had previously been risk-averse and investment in R&D was lower than other countries, leading organisations are looking to increase research spending to 10-12% over the next few years, with biologics and novel chemical entities dominating 4.

Genome 52

Genome Genomics Drugs Life Science 52

BioTech 365

MARCH 24, 2021

Ocean Genomics Partners With Geninus to Co-Develop RNA-Based Biomarkers and Advance Research Ocean Genomics Partners With Geninus to Co-Develop RNA-Based Biomarkers and Advance Research PITTSBURGH–(BUSINESS WIRE)–#RNA–Ocean Genomics (Pittsburgh, PA), a world leader in AI-based gene expression analysis and RNA biomarker … Continue (..)

RNA 52

RNA Genome Genomics Gene Expression 52

BioTech 365

JANUARY 10, 2022

Nashville Biosciences and Illumina Announce Agreement to Establish Preeminent Clinico-Genomic Resource for Life Sciences Research & Development Nashville Biosciences and Illumina Announce Agreement to Establish Preeminent Clinico-Genomic Resource for Life Sciences Research & Development NASHVILLE, Tenn.–(BUSINESS

Life Science 40

Life Science Genome Genomics Development 40

Drug Discovery Today

OCTOBER 27, 2022

The country now hosts the EMBL Partnership Institute for Genome Editing Technologies at the Vilnius University Life Sciences Center aiming to advance gene editing technologies. Six international research groups work at the EMBL Partnership Institute in Vilnius, each tackling a different facet of gene editing. One of them is the Jones!Lab,

Genome 40

Genome Genomics Gene Editing Life Science 40

Drug Discovery Today

NOVEMBER 2, 2022

and Oxford, UK – November 2, 2022 – ROME Therapeutics and Enara Bio, two leading biotechnology companies focused on developing novel medicines driven by insights to the dark genome, today announced that they will host the inaugural Dark Genome Symposium on Monday, November 7, 2022 at ROME’s headquarters in Boston. BOSTON, Mass.

Genome 40

Genome Genomics Research Medicine 40

BioTech 365

OCTOBER 24, 2021

Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research The AVENIO Tumor Tissue Comprehensive Genomic Profiling (CGP) Kit is the first jointly-developed product … Continue reading →

Genome 40

Genome Genomics Research Production 40

BioTech 365

NOVEMBER 9, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Researchers develop program to read any genome sequence and decipher its genetic code.Yekaterina “Kate” Shulgina was a first year student in the Graduate School of Arts and … Continue reading →

Genome 40

Genome Genomics Genetics Development 40

The Pharma Data

NOVEMBER 25, 2021

The International Cancer Genome Consortium (ICGC) is further enabling cancer research worldwide by making a massive collection of cancer data available for analysis via Microsoft’s Azure cloud computing platform. ” ICGC has now moved into its next phase called ICGC ARGO (Accelerating Research in Genomic Oncology). .”

Genome 52

Genome Genomics Research Scientist 52

Drug Discovery World

JUNE 27, 2024

The DDW Summer issue is out now and looks at where the global biotech hubs are for drug discovery and development, asks how 3D genomics can accelerate personalised medicine, and looks at the technological advances in mass spectrometry. Read the digital version here.

Gene Therapy 108

Gene Therapy Genome Genomics Gene 108

Scienmag

SEPTEMBER 7, 2020

Researchers have developed a statistical model that uses genomic data to predict the risk of developing cancer of the oesophagus Credit: Spence Phillips / EMBL-EBI Oesophageal cancer is the eighth most common cancer worldwide. It often develops from a condition called Barrett’s oesophagus.

Genome 52

Genome Genomics Development Research 52

Scienmag

MAY 31, 2021

Paper in Nature Genetics: Genome-wide meta-analysis shows that research into different ancestries leads to better results and better care Credit: The Lundquist Institute LOS ANGELES (May 31, 2021) — Today The Lundquist Institute announced that its investigators contributed data from several studies, including data on Hispanics, African-Americans (..)

Genome 52

Genome Genomics Research Genetics 52

Pharmaceutical Technology

SEPTEMBER 29, 2022

Scribe Therapeutics and Sanofi have signed a strategic partnership to expedite the development of breakthrough clustered regularly interspaced short palindromic repeats (CRISPR)-based cell therapies for cancer. Scribe is also entitled to receive potential payments worth over $1bn on meeting development and commercial milestones.

Development 130

Development In-Vivo Genome Genomics 130

Scienmag

JANUARY 13, 2021

To discover these associations, researchers need to compare the genomes of many individuals at millions of genetic locations or markers, and therefore require cost-effective genotyping technologies. A new statistical method, developed […].

Genome 57

Genome Genomics Genotype Genetics 57